Xiaobei Zeng, Ph.D. - Publications
Affiliations: | 2003 | Johns Hopkins University, Baltimore, MD |
Area:
Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2020 | Tan QL, Zhou CY, Cheng L, Luo M, Liu CP, Xu WX, Zhang X, Zeng X. Immunotherapy of Bacillus Calmette‑Guérin by targeting macrophages against bladder cancer in a NOD/scid IL2Rg‑/‑ mouse model. Molecular Medicine Reports. PMID 32319653 DOI: 10.3892/mmr.2020.11090 | 0.312 | |||
2010 | Zhang W, Zeng X, Briggs KJ, Beaty R, Simons B, Chiu Yen RW, Tyler MA, Tsai HC, Ye Y, Gesell GS, Herman JG, Baylin SB, Watkins DN. A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. Oncogene. 29: 2467-76. PMID 20154726 DOI: 10.1038/Onc.2010.12 | 0.511 | |||
2003 | Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nature Genetics. 33: 197-202. PMID 12539045 DOI: 10.1038/Ng1077 | 0.544 | |||
2000 | Carter MG, Johns MA, Zeng X, Zhou L, Zink MC, Mankowski JL, Donovan DM, Baylin SB. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Human Molecular Genetics. 9: 413-9. PMID 10655551 DOI: 10.1093/Hmg/9.3.413 | 0.534 | |||
Show low-probability matches. |